Maharashtra-based Glenmark Pharmaceuticals launches India's first drug to treat corona virus FabiFlu

Corona virus cases are increasing continuously in the country. So far, 4 lakh 25 thousand 282 people have been infected with Corona. Research is continuing on the medicine and vaccine of this virus worldwide. Meanwhile, Maharashtra-based Glenmark Pharmaceuticals has launched a drug to treat the virus. It will cost Rs 103 per tablet.

This first food medicine in the treatment of corona Earlier on Friday, the company had informed that it received approval from the government for marketing and manufacturing of antiviral drug Fibiflu. The company said on Friday that it had received permission from the Drug Controller General of India (DGCI) to manufacture and market the drug. The company said that Fabiflu is the first food favipiravir drug for the treatment of Kovid-19, which has been approved.

Glenmark Pharmaceuticals chairman and managing director Glenn Saldanha said, "This approval has come at a time when the corona virus cases in India are increasing more rapidly than before." This has put our healthcare system under a lot of pressure. "He hoped that the availability of effective treatment like fibiflu would help reduce this pressure to a great extent.

During the treatment of Corona, Remedesvir and other medicines were used earlier. But Fibiflu is the first medicine that can be eaten. Apart from Remadecivir, some good results were also found for the drug named Dexamethasone.Now the drug Fabiflu has been approved. Now it has to be seen how this drug can help in corona crisis. If this medicine proves helpful in fighting the virus, then the hope of getting success in the fight against Corona will arise.